Guardian Pharmacy Services, Inc. (GRDN) community

GRDNNYSERetail-Drug Stores and Proprietary StoresFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 9/30158% above fair value

$49.52+0.14 (+0.28%)

Close on Nov 13, 2026Market cap $3.14BP/E –Yield –

Community

Notes and questions about Guardian Pharmacy Services from other investors

No posts about GRDN yet

Discussion is coming to every stock. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.

Where these numbers come from

Parsed from the XBRL in Guardian Pharmacy Services's annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is GRDN.

Compare: GRDN vs NHC · GRDN vs PETS · GRDN vs YI · GRDN vs LESLQ · GRDN vs OMCL

Revenue growth4.9% · median -0.0%

Gross margin22.4% · median 33.7%

Operating margin6.5% · median -5.7%

Net margin5.1% · median -6.7%

Company	Revenue	Growth
NHC	$1.58B	+5.6%
GRDN	$1.46B	+4.9%
OMCL	$1.24B	+5.6%
LESLQ	$1.18B	-5.7%
PETS	$160.26M	-19.2%
YI	–	–

Company

Next earnings (est.): Mar 10, 2027, during market hours
Exchange: NYSE
Industry: Retail-Drug Stores and Proprietary Stores
Fiscal year ends: December 31
Employees: 3,600
Held by institutions: 46.6%
Auditor: Ernst & Young LLP
SEC CIK: 1802255

Advertisement
300 × 250

See a number that looks wrong?